U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Guidelines for Assessing the Utility of Data from Prevention of Mother-to-Child Transmission (PMTCT) Programmes for HIV Sentinel Surveillance Among Pregnant Women. Geneva: World Health Organization; 2013.

Cover of Guidelines for Assessing the Utility of Data from Prevention of Mother-to-Child Transmission (PMTCT) Programmes for HIV Sentinel Surveillance Among Pregnant Women

Guidelines for Assessing the Utility of Data from Prevention of Mother-to-Child Transmission (PMTCT) Programmes for HIV Sentinel Surveillance Among Pregnant Women.

Show details

References

1.
Diaz T, et al. New strategies for HIV surveillance in resource-constrained settings: an overview. AIDS. 2005;19(Suppl 2):S1–S8. [PubMed: 15930836]
2.
UNAIDS. Q & A on HIV/AIDS estimates: understanding the latest estimates of the 2007 AIDS epidemic update. Geneva: UNAIDS; 2007.
3.
WHO/UNAIDS. Reconciling antenatal clinic-based surveillance and population-based survey estimates of HIV prevalence in sub-Saharan Africa. Geneva: UNAIDS/WHO; 2003.
4.
UNAIDS/WHO Working Group on Global HIV/AIDS and STI surveillance. Guidelines for conducting HIV sentinel serosurveys among pregnant women and other groups. Geneva: UNAIDS/WHO; 2003.
5.
UNAIDS. Spectrum/EPP 2011. Jun 13, 2011. [18 February 2013]. Available from: http://www​.unaids.org​/en/dataanalysis/tools/spectrumepp2011/
6.
UNAIDS/WHO. Estimating national adult prevalence of HIV-1 in generalized epidemics: EPP manual. Geneva: UNAIDS/WHO; 2009.
7.
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for second generation HIV surveillance. Geneva: UNAIDS/WHO; 2000.
8.
WHO. Guidelines for second generation HIV surveillance: an update: know your epidemic. Geneva: UNAIDS/WHO; (in press) [PubMed: 24049865]
9.
WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010. Geneva: WHO; 2010.
10.
WHO/UNAIDS/UNICEF. Global HIV/AIDS response: epidemic update and health sector progress towards universal access – progress report 2011. Geneva: UNAIDS/WHO/UNICEF; 2011.
11.
UNAIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive: 2011–2015. Geneva: UNAIDS; 2011. [PMC free article: PMC5407381] [PubMed: 28398999]
12.
Action guide for United Nations country teams: implementing the Declaration of Commitment on HIV/AIDS. Meeting a millennium development target: halting HIV/AIDS by 2015. New York: United Nations General Assembly Special Session on HIV/AIDS (UNGASS); 2001.
13.
Rennie S, et al. Conducting unlinked anonymous HIV surveillance in developing countries: ethical, epidemiological, and public health concerns. PLoS Medicine. 2009;6(1):e4. [PMC free article: PMC2628398] [PubMed: 19166264]
14.
UNAIDS/WHO. Ethics in HIV surveillance consultation: meeting report. Geneva: UNAIDS/WHO; 2009.
15.
WHO. Ethical issues in HIV surveillance: guidelines. Geneva: World Health Organization; (in press)
16.
Hladik W, et al. Prevention of mother-to-child transmission and voluntary counseling and testing programme data: what is their utility for HIV surveillance? AIDS. 2005;19(Suppl 2):S19–S24. [PubMed: 15930837]
17.
Seguy N, et al. Can data from programs for the prevention of mother-to-child transmission of HIV be used for HIV surveillance in Kenya? Public Health Reports. 2006;121(6):695–702. [PMC free article: PMC1781911] [PubMed: 17278404]
18.
UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010.
19.
Kanshana S, Simonds RJ. National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned. AIDS. 2002;16(7):953–959. [PubMed: 11953461]
20.
Ministry of Public Health, Thailand. Perinatal HIV intervention monitoring system (PHIMS) report. Bangkok: Bureau of Health Promotion, Department of Health, Thailand Ministry of Public Health; 2011.
21.
Ministry of Public Health, Thailand. HIV serosurveillance annual report. Bangkok: Bureau of Epidemiology, Thailand Ministry of Public Health; 2011.
22.
Seipone K. Utility of PMTCT program data for HIV surveillance in Botswana: preliminary results; 2nd Global HIV/AIDS Surveillance Meeting (Session VIIB); Bangkok, Thailand. 2009.
23.
Macauley I, et al. HIV prevalence among PMTCT clients and sentinel surveillance in Cameroon; XV International Conference on AIDS; 11–16 July 2004; Bangkok, Thailand. 2004. [Abstract no. MoPeC3590]
24.
Fabiani M, et al. Adjusting HIV prevalence data from a program for the prevention of mother-to-child transmission for surveillance purposes in Uganda. Journal of Acquired Immune Deficiency Syndromes. 2007;46(3):328–331. [PubMed: 17786127]
25.
Fabiani M, et al. Using prevalence data from the programme for the prevention of mother-to-child-transmission for HIV-1 surveillance in North Uganda. AIDS. 2005;19(8):823–827. [PubMed: 15867497]
26.
Ministry of Public Health and Sanitation, Kenya. Utility of prevention of mother-to-child HIV transmission program data for HIV surveillance in Kenya: methods, findings, and recommendations. Nairobi: Kenya National AIDS and STD Control Program, Ministry of Public Health and Sanitation; 2011.
27.
Ministry of Public Health and Sanitation, Kenya. Sentinel surveillance for HIV and syphilis among pregnant women, 2010. Nairobi: Kenya National AIDS and STI Control Program, Ministry of Public Health and Sanitation; 2010.
28.
Bolu O, et al. Utility of antenatal HIV surveillance data to evaluate prevention of mother-to-child HIV transmission programs in resource-limited settings. American Journal of Obstetrics and Gynecology. 2007;197(3 Suppl):S17–S25. [PubMed: 17825646]
29.
Meda N, et al. HIV infection among pregnant women in Bobo-Dioulasso, Burkina Faso: comparison of voluntary and blinded seroprevalence estimates. International Journal of STD and AIDS. 1999;10(11):738–740. [PubMed: 10563562]
30.
Gonese E, et al. Comparability of antenatal clinic (ANC) survey and prevention from mother to child transmission (PMTCT) programme data, Zimbabwe, 2004; XVI International AIDS Conference; 13–18 August 2006; Toronto, Canada. 2006. [Poster No. TUPE0309]
31.
Mpairwe H, et al. HIV risk perception and prevalence in a program for prevention of mother-to-child HIV transmission: comparison of women who accept voluntary counseling and testing and those tested anonymously. Journal of Acquired Immune Deficiency Syndromes. 2005;39(3):354–358. [PubMed: 15980698]
32.
Francoise Kayibanda J, et al. Use of routine data collected by the prevention of mother-to-child transmission program for HIV surveillance among pregnant women in Rwanda: opportunities and limitations. AIDS Care. 2011;23(12):1570–1577. [PubMed: 21732899]
33.
Marsh KA, et al. Can PMTCT program data replace HIV sentinel surveillance among pregnant women in Africa? Journal of HIV/AIDS Surveillance and Epidemiology. 2010;2(1)
34.
Martin-Herz SP, et al. Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe. International Journal of STD and AIDS. 2006;17(12):835–841. [PubMed: 17212862]
35.
Fabiani M, et al. Investigating factors associated with uptake of HIV voluntary counselling and testing among pregnant women living in North Uganda. AIDS Care. 2007;19(6):733–739. [PubMed: 17573592]
36.
Mkwanazi NB, et al. Rapid testing may not improve uptake of HIV testing and same day results in a rural South African community: a cohort study of 12,000 women. PLoS ONE. 2008;3(10):e3501. [PMC free article: PMC2567429] [PubMed: 18946509]
37.
Westheimer EF, et al. Acceptance of HIV testing among pregnant women in Dar-es-Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes. 2004;37(1):1197–1205. [PubMed: 15319681]
38.
Pignatelli S, et al. Factors predicting uptake of voluntary counselling and testing in a real-life setting in a mother-and-child center in Ouagadougou, Burkina Faso. Tropical Medicine and International Health. 2006;11(3):350–357. [PubMed: 16553915]
39.
Sarker M, et al. Determinants of HIV counselling and testing participation in a prevention of mother-to-child transmission programme in rural Burkina Faso. Tropical Medicine and International Health. 2007;12(12):1475–1483. [PubMed: 18076555]
40.
Urassa M, et al. Effect of PMTCT availability on choice of ANC in Mwanza and Magu districts and its impact on HIV sentinel surveillance. Report to WHO SURVART Programme. 2007. [17 February 2013]. (unpublished). Available at: http://www​.tazamaproject​.org/pub0012.shtml.
41.
Local Fund Agent (LFA) guidelines for on-site data verification and rapid services quality assessment implementation. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2011.
42.
Parekh BS, et al. Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance. American Journal of Clinical Pathology. 2010;134(4):573–584. [PubMed: 20855638]
43.
WHO. Guidelines for assuring the accuracy and reliability of HIV rapid testing: applying a quality system approach. Geneva: WHO/CDC; 2005.
44.
WHO. Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation–2009 update. Geneva: WHO; 2009. [PubMed: 26203489]
45.
CIOMS/WHO. International ethical guidelines for epidemiological studies. Geneva: Council for International Organizations of Medical Sciences (CIOMS) and WHO; 2009.
46.
WHO. HIV antigen/antibody assays: operational characteristics: report 16 – rapid assays. Geneva: WHO; 2009.
47.
WHO. HIV assays: operational characteristics: report 15 – antigen/antibody ELISAs. Geneva: WHO; 2004.
48.
Staquet M, et al. Methodology for the assessment of new dichotomous diagnostic tests. Journal of Chronic Diseases. 1981;34(12):599–610. [PubMed: 6458624]
Copyright © World Health Organization 2013.

All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK158997

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...